Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 236 participants.

Also called NCT04486430

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 236 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04486430
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04486430. Randomized; triple masking; primary purpose treatment. Start 2017-03-02 (actual); primary completion 2019-06-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset
Acronym
Salfaprodil
Condition
Stroke
Condition
Cerebral Infarction
Intervention (Drug)
Neu2000KWL
Intervention (Drug)
Neu2000KWL
Intervention (Drug)
Neu2000KWL
Intervention (Drug)
Placebos
Lead sponsor
Beijing Tiantan Hospital (class: other)
Collaborator
Zhejiang Apeloa Jiayuan Pharmaceutical Co. Ltd. (class: not stated)
Collaborator
Subei People's Hospital of Jiangsu Province (class: other)
Collaborator
The First Hospital of Jilin University (class: other)
Collaborator
First Hospital of China Medical University (class: other)
Collaborator
General Hospital of Shenyang Military Region (class: other)
Collaborator
The First Affiliated Hospital of BaoTou Medical College (class: other)
Collaborator
Xuanwu Hospital, Beijing (class: other)
Collaborator
Peking University First Hospital (class: other)
Collaborator
Peking University Third Hospital (class: other)
Collaborator
Tianjin First Central Hospital (class: other)
Collaborator
Tianjin Huanhu Hospital (class: other)
Collaborator
Hebei Medical University Third Hospital (class: other)
Collaborator
The Second Hospital of Hebei Medical University (class: other)
Collaborator
Hebei General Hospital (class: other)
Collaborator
Second Hospital of Shanxi Medical University (class: other)
Collaborator
Shandong Provincial Hospital (class: other government)
Collaborator
Qilu Hospital of Shandong University (class: other)
Collaborator
The First Affiliated Hospital of Soochow University (class: other)
Collaborator
Nanjing PLA General Hospital (class: other)
Collaborator
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (class: other)
Collaborator
Shanghai Minhang Central Hospital (class: other)
Collaborator
First Affiliated Hospital of Zhejiang University (class: other)
Collaborator
Second Affiliated Hospital, Zhejiang University, School of Medicine (class: other)
Collaborator
First Affiliated Hospital of Wenzhou Medical University (class: other)
Collaborator
Xiangya Hospital of Central South University (class: other)
Collaborator
Guangzhou First People's Hospital (class: other)
Collaborator
Second Affiliated Hospital of Guangzhou Medical University (class: other)
Collaborator
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (class: other)
Collaborator
Nanfang Hospital, Southern Medical University (class: other)
Collaborator
First Affiliated Hospital of Jinan University (class: other)
Collaborator
Tongji Hospital (class: other)
Collaborator
The Central Hospital of Lishui City (class: other)
Collaborator
Shanghai Pudong New Area People's Hospital (class: other)
Collaborator
Inner Mongolia Baogang Hospital (class: other)
Collaborator
Daqing Oil Field Hospital (class: other)

Registry records

Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry organizations 27

Record details

Record id
cardio:ct-nct04486430
Content hash
2db7c4ceaee6f11baf4ec50444551c2def204b1d17d9d992e4e04affaab86ba4